Efficacy of dupilumab as an alternative to corticosteroids in the treatment of exacerbations of allergic bronchopulmonary aspergillosis

被引:1
|
作者
Hamakawa, Masamitsu [1 ,2 ]
Ishida, Tadashi [1 ]
机构
[1] Kurashiki Cent Hosp, Dept Resp Med, Okayama, Japan
[2] Kurashiki Cent Hosp, Dept Resp Med, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan
来源
RESPIROLOGY CASE REPORTS | 2024年 / 12卷 / 04期
关键词
ABPA; allergic bronchopulmonary aspergillosis; asthma; dupilumab;
D O I
10.1002/rcr2.1354
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The pathogenesis of allergic bronchopulmonary aspergillosis involves not only eosinophils but also plasma cells that produce immunoglobulin E. Dupilumab may be an effective alternative to corticosteroids because it inhibits T cell to plasma cell differentiation by blocking IL4. The pathogenesis of ABPA involves not only eosinophils but also plasma cells that produce IgE, which is responsible for type I allergic mechanisms. Dupilumab may be an effective alternative to corticosteroids because it inhibits T cell to plasma cell differentiation by blocking IL4. image
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Diagnosis and treatment of allergic bronchopulmonary aspergillosis
    Nichole T. Tanner
    Marc A. Judson
    Current Fungal Infection Reports, 2008, 2 (4)
  • [22] Omalizumab treatment in allergic bronchopulmonary aspergillosis
    Sousa, F.
    Mendes, A.
    Barbosa, M.
    ALLERGY, 2010, 65 : 552 - 552
  • [23] TREATMENT OF BRONCHOPULMONARY ASPERGILLOSIS WITH ALLERGIC MANIFESTATIONS
    ANTONOV, VB
    MITROFANOV, VS
    SOBOLEV, AV
    YAROBKOVA, ND
    TERAPEVTICHESKII ARKHIV, 1994, 66 (03) : 61 - 63
  • [24] Diagnosis and treatment of allergic bronchopulmonary aspergillosis
    Vlahakis, NE
    Aksamit, TR
    MAYO CLINIC PROCEEDINGS, 2001, 76 (09) : 930 - 938
  • [25] Antifungals in the treatment of allergic bronchopulmonary aspergillosis
    Leon, EE
    Craig, TJ
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (06) : 511 - 517
  • [26] Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis
    Tanner, Nichole T.
    Judson, Marc A.
    CURRENT FUNGAL INFECTION REPORTS, 2008, 2 (04) : 199 - 205
  • [27] DUPILUMAB EFFICACY IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND SEROLOGIC EVIDENCE OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
    Corren, J.
    Sher, L.
    Zhu, X.
    Rice, M.
    Deniz, Y.
    Rowe, P.
    Staudinger, H.
    Ruddy, M.
    Patel, N.
    Graham, N.
    Teper, A.
    Amin, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S15 - S15
  • [28] Double the Trouble, Double the Fun: Dupilumab Treatment in a Patient with Severe Asthma and Allergic Bronchopulmonary Aspergillosis
    Ramonell, R. P.
    Kuruvilla, M. E.
    Swenson, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [29] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma and Serologic Evidence of Allergic Bronchopulmonary Aspergillosis
    Corren, J.
    Sher, L.
    Zhu, X.
    Rice, M. S.
    Deniz, Y.
    Rowe, P.
    Staudinger, H. W.
    Ruddy, M.
    Patel, N.
    Graham, N. M. H.
    Teper, A.
    Amin, N.
    PNEUMOLOGIE, 2020, 74 : S89 - S89
  • [30] LYMPHOCYTE-ACTIVATION DURING AND AFTER EXACERBATIONS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
    GREENBERGER, PA
    GRAMMER, LC
    GOULSBY, C
    CLINICAL RESEARCH, 1994, 42 (03): : A385 - A385